Contineum Therapeutics
CTNM
#7071
Rank
A$0.71 B
Marketcap
A$19.57
Share price
-7.48%
Change (1 day)
62.76%
Change (1 year)

Earnings for Contineum Therapeutics (CTNM)

Earnings in 2025 (TTM): -A$92.77 Million

According to Contineum Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$59.68 Million a decrease over its 2023 earnings that were of A$32.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Contineum Therapeutics from 2023 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$92.77 Million55.46%
2024 -A$59.68 Million-282.38%
2023 A$32.71 M